MODULATION OF COLLAGEN-BINDING INTEGRINS AFFECTS FIBROBLAST ACTIVATION AND INHIBITS FIBROSIS
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
The extracellular matrix contributes to the progression of several diseases, sometimes by disrupting organ function such as in lung and liver fibrosis. Because integrin receptors mediate cell-matrix interactions, we conditionally deleted β1 integrin in murine hepatocytes in vivo . Increased TGF-β and matrix deposition ensued. Application of a cyclic peptide (GLQGE) that binds to both α10β1 and α11β1 diminished fibrosis in two murine models. In liver fibrosis, TGF-β production was reduced. In lung fibrosis, however, the effect was exclusively due to suppressing fibroblast activation and hence collagen production without TGF-β involvement.
In summary, integrin manipulation successfully changed cell behavior, with effects differing depending on the cell type. Importantly, it is possible to directly suppress fibroblast activation and consequently diminish matrix production independent of disease pathogenesis. This underscores the importance of matrix composition in modifying the behavior of embedded cells and hence disease severity.
Key findings
-
Loss of α11β1 integrin-mediated signal in hepatocytes increases TGF-β and leads to fibrosis
-
Engaging α10β1 and/or α11β1 with a cyclic peptide (GLQGE) inhibits fibroblast activation directly and, consequently matrix production and progression of fibrosis